Flerie ABFRA:1NP1 -0.29%28 FCF Yield % is -1.65 as of Jul. 03, 2026. GuruFocus rates FRA:1NP1 with a GF Score™ of 28/100. The stock has 1 warning sign investors should review. Among 1,413 Biotechnology companies, Flerie AB ranks better than 76.57% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Flerie AB FCF Yield % Related Terms
Flerie AB FCF Yield % Historical Data
* Premium members only.
The historical data trend for Flerie AB's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:1NP1 vs VRTX, REGN, ALNY: FCF Yield % Comparison
For the Biotechnology subindustry, Flerie AB's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Flerie AB FCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Flerie AB's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Flerie AB's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Flerie AB (FRA:1NP1) has a FCF Yield % of -1.65 as of Jul. 03, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Flerie AB and its competitors. According to the industry distribution chart, Flerie AB ranks #331 out of 1413 companies in the Biotechnology industry, placing it in the top 23.4%.
Is Flerie AB's FCF Yield % too high?
Flerie AB's current FCF Yield % is -1.65. Based on the distribution chart, Flerie AB ranks #331 out of 1413 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Flerie AB has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Flerie AB's FCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Flerie AB ranks #331 out of 1413 companies for FCF Yield %. This places Flerie AB in the top 23% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Flerie AB and its competitors. Flerie AB's current FCF Yield % is -1.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Flerie AB stock overvalued right now?
Flerie AB (FRA:1NP1) has a current FCF Yield % of -1.65. The current FCF Yield % is -1.65. Flerie AB's overall GF Score™ is 28/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Flerie AB (FRA:1NP1), the current FCF Yield % is -1.65 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Flerie AB is a pharmaceutical company focusing on immunological diseases with great medical needs for new treatment options. The portfolio of the company includes Immuno-Oncology, metabolic diseases, and biologics development and manufacturing organizations. It operates in two segments The Product Development segment, and The Commercial Growth segment. The Product Development segment consists of early and mid-stage biotech and pharma companies advancing their products and technologies toward clinical proofof-concept and marketing approvals. The Commercial Growth segment consists of companies already selling products or services, showcasing their ability to generate increasing revenues ahead of reaching sustainable profitability.
28GF Score
Get the complete analysis for FRA:1NP1
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:1NP1 has been successfully added to your 
